Clinical usefulness of measuring the number of Circulating Tumor Cells (CTC) in breast cancer patients
Journal Title: OncoReview - Year 2013, Vol 3, Issue 3
Abstract
Background: Monitoring the breast cancer patients after an adjuvant therapy usually involves imaging methods or biopsy. Alternatively, breast cancer markers can be determined – one of them is the number of circulating tumor cells (CTC).Aim: The aim of this study was to compare the efficacy of standard monitoring methods and those based on CTC count.Materials and methods: Systematic review of PubMed database was performed. Inclusion criteria were met by 16 clinical trials, 9 reviews and 5 treatment recommendations.Results: CTC assay sensitivity was between 39% and 55% compared to the imaging, and 64% in combination with CA 27.29 (cancer antigen 27.29) marker. CTC specificity for the detection level of < 5 or ≥ 5 CTCs in blood was almost 100%. CTC assay enables correct classification of patients according to the neoplastic disease progression. Overall survival (OS) and progression free survival (PFS) were correlated with blood CTCs in metastatic patients. The study results suggest a link between CTC level and imaging diagnosis. Patients with CTC ≥ 5 were at a higher risk of disease progression, as diagnosed by radiographic methods, than patients with CTC < 5.Conclusions: Blood CTC measurement is a good clinical predictor of overall survival and progression-free survival and can be used for treatment efficacy monitoring in patients at high risk of recurrence or progression during advanced breast cancer treatment.
Authors and Affiliations
Dariusz Brenski
Keywords
Related Articles
- EP ID EP67724
- DOI -
- Views 229
- Downloads 0
Ifosfamide-induced encephalopathy in a patient with metastatic fibrosarcoma
Ifosfamide is a cytostatic drug commonly used in chemotherapy. One of the common adverse effects resulting from the treatment with ifosfamide is encephalopathy. This paper describes a case study of a 64-year-old patient...
Application of molecular markers in the diagnostics of thyroid focal lesions – current state of knowledge
Thyroid nodular disease is a common disorder and affects about 20% of adult polish population. Due to the fact that methods currently applied in routine assessment of these changes often do not provide accurate diagnosis...
Żylne cewniki centralne do chemioterapii a powikłania kardiologiczne
Trwały dostęp naczyniowy ma ogromne znaczenie w leczeniu chorych onkologicznych poddawanych długotrwałej chemioterapii. Prezentujemy dwa przypadki, wczesnych i późnych, powikłań związanych z obecnością centralnego cewnik...
Rola eksemestanu w leczeniu raka piersi
Leczenie hormonalne jest jedną z podstawowych opcji terapeutycznych w leczeniu raka piersi, zarówno miejscowo zaawansowanego, jak i przerzutowego. Standardem od wielu lat pozostaje tamoksyfen, jednak wyniki nowych badań...
Novel oral anticoagulants in the treatment of cancer patients
Cancer and its treatment are well-recognized risk factors for venous thromboembolism. The risk of thrombotic complications increases 4–7-fold in cancer patients and coexistence of both pathologies is associated with shor...